The act has been reintroduced to remove regulatory barriers that inhibit researchers from obtaining marijuana plans to conduct studies on medical effectiveness and safety.
Evidence from neurobiological research points to cannabinoids as possible therapeutic agents of interest for PTSD, a condition that over 3.5 million people suffer with in the USA alone.
Western University researchers have found a way to use pharmaceuticals to reverse the negative psychiatric effects of THC.
New York University study investigates the common use of 'Spice' among high school students and high risk of health issues related to synthetic cannabinoid use.
Emerald Health Bioceuticals has created a legal CBD oil alternative for states where medical marijuana has not been legalized.
Neuroscientists have found cannabidiol reduces symptons such as impaired memory in mice when exposed to THC.
The University of Westminster is organizing a lecture for the public titled, ‘Cannabis and Epilepsy: Past, Present and Future’ discussing the use of cannabis in the treatment for epilepsy.
New research suggests that cannabis users have higher cerebral blood flow as THC levels directly change how the brain utilizes oxygen.
U.S. government examples of cannabis, used in research, fail to replicate the cannabis that's available on the market.